Cardiovascular Action of Insulin in Health and Disease: Endothelial L-Arginine Transport and Cardiac Voltage-Dependent Potassium Channels

Abstract

Impairment of insulin signaling on diabetes mellitus has been related to cardiovascular dysfunction, heart failure, and sudden death. In human endothelium, cationic amino acid transporter 1 (hCAT-1) is related to the synthesis of nitric oxide (NO) and insulin has a vascular effect in endothelial cells through a signaling pathway that involves increases in hCAT-1 expression and L-arginine transport. This mechanism is disrupted in diabetes, a phenomenon potentiated by excessive accumulation of reactive oxygen species (ROS), which contribute to lower availability of NO and endothelial dysfunction. On the other hand, electrical remodeling in cardiomyocytes is considered a key factor in heart failure progression associated to diabetes mellitus. This generates a challenge to understand the specific role of insulin and the pathways involved in cardiac function. Studies on isolated mammalian cardiomyocytes have shown prolongated action potential in ventricular repolarization phase that produces a long QT interval, which is well explained by attenuation in the repolarizing potassium currents in cardiac ventricles. Impaired insulin signaling causes specific changes in these currents, such a decrease amplitude of the transient outward K⁺ (Ito) and the ultra-rapid delayed rectifier (IKur) currents where, together, a reduction of mRNA and protein expression levels of α-subunits (Ito, fast; Kv 4.2 and IKs; Kv 1.5) or β-subunits (KChIP2 and MiRP) of K⁺ channels involved in these currents in a MAPK mediated pathway process have been described. These results support the hypothesis that lack of insulin signaling can produce an abnormal repolarization in cardiomyocytes. Furthermore, the arrhythmogenic potential due to reduced Ito current can contribute to an increase in the incidence of sudden death in heart failure. This review aims to show, based on pathophysiological models, the regulatory function that would have insulin in vascular system and in cardiac electrophysiology.

General overview of cardiovascular regulation by insulin in health and disease

Insulin is a peptide hormone produced by the β cells, of the islets of Langerhans. Functionally, is the most potent anabolic hormone, promoting the synthesis and storage of carbohydrates, lipids and proteins, while inhibiting their degradation and release into circulation. This hormone stimulates the uptake of glucose, amino acids, and fatty acids; and increases the expression of enzymes involved in the glycogen, lipid, and protein synthesis. At the same time, it reduces the activity of the enzymes that catalyse degradation of same molecules (Saltiel and Kahn, 2001). Cellular effects of insulin are mediated by the activation of insulin receptors (IRs A/B), and a signaling pathway involved in the regulation of nutrients metabolism, mitochondrial biogenesis, cellular grown, proliferation, differentiation, and migration (Nystrom and Quon, 1999). IRs are glycoproteins consisting of an extracellular α-subunit (135 kDa) and a transmembrane β-subunit (95 kDa). These receptors are allosteric enzymes in which the α-subunit regulates tyrosine kinase activity of the β-subunits. The binding of insulin to the α-subunit results in dimerization, forming the α₂β₂ complex in the plasma membrane. The complex α₂β₂ generates the autophosphorylation of β-subunit at tyrosine (Tyr) 1158 (Tyr¹¹⁵⁸), Tyr¹¹⁶², and Tyr¹¹⁶³, the first step in the activation cascade induced by insulin (Patti and Kahn, 1998). Phosphorylation of IR induces the tyrosine kinase activity toward insulin receptor substrate (IRS) 1 (IRS-1) or 2 (IRS-2), generating binding sites for Src homology 2 (SH2) domain proteins, including phosphatidylinositol 3-kinase (PI3K), RAS guanine nucleotide exchange factor complex known as growth factor receptor-bound protein 2/son of sevenless (GRB2/SOS), and SH2 domain-containing protein tyrosine phosphatase-2 (SHP2) and other SH2 proteins (Copps and White, 2012). These proteins provide specific docking sites for the recruitment of downstream signaling proteins, leading to activation of mitogen-activated protein kinase (MAPK), protein kinase B (PKB/Akt) and protein kinase C (PKC) signaling cascades (White, 2003; Schultze et al., 2012).

Since the early nineties, the cardiovascular actions of insulin have been studied in humans, and the main information was collected in several works published by Alain Baron and Helmut Steinberg. In 1990, in a study made in obese and lean subjects determined a correlation between insulin resistance (hyperglycaemia and hyperinsulinemia), and lack of vasodilatory effects of insulin in leg blood flow (LBF). These obese subjects showed a lower capacity for uptake D-glucose and changes in cardiac function, such as reduction in cardiac index [cardiac output (CO)/body surface area] and stroke volume (SV) without change in heart rate (HR) (Baron et al., 1990). Authors concluded that insulin resistance could be a result of insulin's actions both in glucose uptake and hemodynamic regulation, highlighting the in vivo role of insulin as an endocrine regulator of cardiovascular physiology. Later, healthy subjects under a protocol of euglycemic hyperinsulinemia showed increases of CO, SV, HR, and LBF; and decreases of mean arterial pressure (MAP), systemic vascular resistance (SVR), and leg vascular resistance (LVR). Correlation analysis showed that the insulin-mediated glucose uptake is inversely proportional to MAP or SVR, supporting the hemodynamic basis for insulin resistance (Baron et al., 1993). The effects of insulin are part of physiological regulation of cardiovascular system, with a delicate interaction with other signals, like norepinephrine (NE) and acetylcholine (Ach). Obese insulin-resistant subjects show more sensitivity to contractile effects of NE, and lower clearance of NE in response to insulin (Baron et al., 1994). More recently, a reduction was shown in Ach-dependent forearm blood flow in obese patients, but this effect disappears in the group of obese subjects without metabolic syndrome (Schinzari et al., 2015). Even though it is not possible to discard a deleterious effect of obesity per se on the cardiovascular system, mechanisms that we discuss in this review show that insulin resistance could be a primary cause of cardiovascular disease in metabolic disorders, leading to a deterioration of endothelium-dependent vasodilatation and higher sensibility to vasoconstrictors, like NE or other locally released molecules. The accumulated evidence shown by the literature makes it possible to establish that insulin-dependent blood flow increments are blunted in obese, and type 2 diabetes mellitus (T2DM) patients, conditions associated with insulin resistance. Physiological regulation of blood flow by insulin depends on a mechanism that involves the activation of PI3K, PKB, and nitric oxide (NO) synthesis (Baron, 2002; Steinberg and Baron, 2002). Due to the increasing prevalence of diabetes and insulin resistance, a main objective of this article is to make a critical review of physiological mechanisms regulated by insulin both in vasculature and in the heart. Thus, we can propose a hypothesis for pathological mechanisms of cardiovascular disease in diabetes or insulin resistance.

Diabetes mellitus (DM) is characterized by chronic hyperglycaemia which results from defects in insulin secretion (type 1 DM), insulin action (T2DM), or both (WHO, 1998). Diabetes is a common disease that affects ~382 million people worldwide, and the costs to society are high and escalating. By the end of 2013, diabetes caused 5.1 million deaths and cost USD 548 billion in healthcare spending (IFD, 2013). Although treatment has been improved over the last decades, diabetes is related with several complications like acute hyperglycaemic or hypoglycaemic events, kidney disease, eye disease, peripheral vascular disease, coronary artery disease, cerebrovascular disease, and congestive heart failure (Bethel et al., 2007).

Cardiovascular diseases (CVD) represent the leading causes of morbidity and mortality in patients with diabetes (Gregg et al., 2014), with cardiac and vascular dysfunctions as key steps of the pathophysiological mechanism. Vascular dysfunction is primarily caused by endothelial dysfunction, a phenomenon related with deterioration in the capacity of these cells to synthesize NO. NO is synthesized from the semi-essential cationic amino acid L-arginine and molecular oxygen (O₂) by endothelial NO synthase (eNOS), leading to the formation of NO and the neutral amino acid L-citrulline (Palmer et al., 1988). The enzyme depends on several cofactors, including Ca²⁺/calmodulin complex, tetrahydrobiopterin (BH₄), nicotinamide adenine dinucleotide phosphate (NADPH), flavin adenine dinucleotide (FAD), and flavin mononucleotide (FMN) (Knowles and Moncada, 1994; Sessa, 1994). In absence of NO signaling there is a disturbance in vascular homeostasis, triggering a series of events leading to pathologies like as hypertension, hypercholesterolemia, renal vascular insufficiency, and chronic heart failure (Vanhoutte, 2003; Wierzbicki et al., 2004; Yang et al., 2007). As mentioned above, several studies in diabetic patients have demonstrated deficiency in endothelium-dependent vasodilation, a disturbance that generates an imbalance in vascular tone, which ultimately leads to the development of endothelial dysfunction (Williams et al., 1996; Rask-Madsen and King, 2007). Mechanisms underlying the decrease in NO-dependent dilatation in diabetes include decreased bioavailability of tetrahydrobiopterin (BH4) cofactor and uncoupling of eNOS (Cai et al., 2005), increased activity of arginase (an enzyme that competes with the eNOS for L-arginine; Vanhoutte and Tang, 2008), high levels of asymmetric dimethylarginine (ADMA, endogenous inhibitor of eNOS; Xiong et al., 2003); increased production of superoxide anion () and peroxynitrite (ONOO⁻) synthesis (Cosentino et al., 2003; Quijano et al., 2007), inactivation of NO by advanced glycation end products (Gao et al., 2008) and abnormal responses of vascular smooth muscle cells (VSMC) (Lesniewski et al., 2008; Shi and Vanhoutte, 2008).

On the other hand, a main cardiac disorder is diabetic cardiomyopathy (DCM), a pathology associated with alterations in molecular metabolism and structure of cardiomyocytes (Fang et al., 2004). These changes include, among others, a ventricular electric remodeling characterized by long-term alterations in ion channel activity that could be a compensatory or adaptive mechanism (Casis and Echevarria, 2004). Electrical remodeling has been related with contractile failure due to abnormal increase of intracellular Ca²⁺ concentration or to arrhythmias that lead to sudden death (Straus et al., 2006). Most electrical disturbances are related to the abnormal repolarization of cardiac action potential (Shimoni et al., 2004). Electrophysiological studies have clearly identified the different types of voltage-dependent currents (inward or outward currents), which contribute to the repolarization phase in the mammalian myocardium (Nerbonne and Kass, 2005). Outward currents are clearly differentiated and cardiac myocyte express voltage-dependent K⁺ channels (Kv) that contribute to the development of action potential (Nerbonne, 2000). Changes in the functional properties of the Kv channels can generate dramatic effects in myocardial action potential, and also in the normal cardiac rhythm generation (Lengyel et al., 2007). Cardiovascular complications in diabetes have been associated to a series of electrocardiographic disturbances, such as QT interval prolongation, even in short-term diabetes (Veglio et al., 2002a,b; Zhang et al., 2011). Experimental evidence suggests that specific remodeling of some K⁺ channels in the ventricle is related with these alterations (Casis and Echevarria, 2004).

Insulin regulation of vascular system

Relevance of L-arginine transport in vascular physiology

In endothelial cells, uptake of the substrate L-arginine for NO synthesis is mediated by transport systems called y⁺, y⁺L, b^{0, +}, and B^{0, +}. The main transport system involved in this process is the system y⁺, responsible for ~85% of L-arginine transport in physiological state (Devés and Boyd, 1998). This system includes the family of proteins known as cationic amino acids transporters (CATs), formed by CAT-1, CAT-2A, CAT-2B, CAT-3, and CAT-4 (Verrey et al., 2004; Casanello et al., 2007). Members of the CATs family are encoded by genes SLC7A 1, 2, 3, and 4 (Verrey et al., 2004). CAT-1, encoded by SLC7A1 gene, is ubiquitously expressed, while CAT-2A and CAT-3 are constitutively expressed in liver and brain, respectively. CAT-2B is induced under inflammatory conditions in a variety of cells including T cells and macrophages. The CAT-4 gene sequence is 41–42% identical to the other members of the family CATs, but its transport activity has not been described. The function of CATs was suggested because of their structural similarity to Saccharomyces cerevisiae, permease for L-histidine and L-arginine. Its function was verified by expression in Xenopus laevis oocytes for kinetic transport studies (Closs et al., 1997). CAT-1, CAT-2B, and CAT-3 are Na⁺ independent transporters, presenting medium affinity for its substrate (K_m ~50–250 μM), whereas CAT-2A has low affinity for cationic amino acids (K_m ~2–5 mM) (Devés and Boyd, 1998; Palacín et al., 1998; Mann et al., 2003).

In cytoplasm, L-arginine is used for synthesis of proteins, NO, urea, creatine, agmatine, polyamines, and other molecules. Intracellular concentration of L-arginine is near to 1 mM, but the K_m of eNOS by L-arginine is ~3 μM and, as mentioned, the K_m of hCAT-1/2B for L-arginine is ~50–250 μM (Shin et al., 2011). These inconsistencies between cytoplasmic concentrations of L-arginine and the affinity for substrate of L-arginine/NO system, constitutes the “L-arginine paradox.” This paradox is under discussion among researchers, especially given the growing relevance of L-arginine transport from extracellular space and the concept of compartmentalization of different pools of L-arginine (Karbach et al., 2011; Simon et al., 2013). In a simple but very elegant experiment, Shin et al. demonstrated that L-arginine transport mediated by a facilitated diffusion system is absolutely necessary for NO synthesis: when EA.hy926 endothelial cells are incubated with modified L-arginine, which has the ability to enter cells by passive diffusion, eNOS is not able to synthesize NO. Additionally, in knockdown cells for hCAT-1 (induced by siRNA), L-citrulline synthesis is significantly reduced, showing the relevance of this specific transporter (Shin et al., 2011). This evidence is supported by hCAT-1 localization studies. In porcine aortic endothelial cells (PAEC) CAT-1 colocalize with eNOS and caveolin-1 (Cav-1, structural protein of caveolae; McDonald et al., 1997). The subcellular localization through overexpression of CAT-1 fused to green fluorescent protein (GFP) has been studied in different cell lines (Closs et al., 2006). In hamster kidney baby cells (HKB) it has been noted that CAT-1-GFP is localized predominantly in caveolin associated domains in plasma membrane (Lu and Silver, 2000). In another study, CAT-1-EGFP was mainly found in intracellular vesicles of U373MG, human glioblastoma cells, and to a lesser extent a lesser extent in the plasma membrane (Wolf et al., 2002). In Madin-Darby canine kidney epithelial cells (MDCK) and human embryonic kidney 293 cells (HEK293), the expression of CAT-1-GFP was detected, predominantly in the basolateral plasma membrane (Cariappa et al., 2002; Kizhatil and Albritton, 2002). Meanwhile, more research into HEK293 showed that mCAT-1-GFP is located in filopodia, and near to Golgi (Masuda et al., 1999). Recently, Guo et al. showed that CAT-1-GFP it expressed in plasma membrane in colocalization with VE-caherin and the authors propose that CAT-1 have a role as cellular adhesion molecule (CAM) and that the incubation with extracellular L-arginine augments L-arginine transport via promoting the CAT-1 shift from endothelial cells junctions to the free surface of ECs (Guo et al., 2015). Therefore, the L-arginine paradox has a potential explanation in the characteristics of CAT-1 cell surface expression, generating functional clusters for ensure an adequate supply of L-arginine for eNOS activity. Due to their physiological relevance, we focus on determining changes induced by insulin and/or diabetes on activity and expression of CAT-1.

Regulation of hCAT-1 by insulin in normoglycaemic or hyperglycaemic environment

Insulin increases the mRNA expression levels of hCAT-1 and hCAT-2B in human umbilical vein endothelial cells (HUVEC), correlates with high rate of L-arginine transport and NO synthesis (González et al., 2004) in a mechanism that involves high abundance of the protein in the plasma membrane (González et al., 2011). Insulin exerts a vasodilatory effect (González et al., 2011; Guzmán-Gutiérrez et al., 2012) through a signaling pathway involving PI3K, PKB/Akt, and MAPK activity that activates hCAT-1 and eNOS in endothelial cells (González et al., 2004). It has been described that this stimulation by insulin is caused by the activation of the promoter of the SLC7A1, gene encoding hCAT-1, via a mechanism that involves multiple binding sequences for the transcriptional factor specificity protein 1 (Sp1), located between 117 and 105 upstream base pairs from the transcription start site (TSS) (González et al., 2011). The SLC7A1 promoter belongs to the TATA-less group, so binding sites for Sp1 located near the TSS would be responsible for both basal expression and regulation of gene expression to stimulation by growth factors (Sobrevia and González, 2009). These effects have been observed with physiologic concentrations of insulin (0.1–10 nM), so we propose that the expression of SLC7A1 and hCAT-1 activity would be under a tonic regulation by physiological levels of plasma insulin. Moreover, it is reported that similar concentrations of insulin (1 μM) induces an acute (5 min) increase of L-arginine transport by a mechanism dependent on PI3K activity and PKC in human aortic endothelial cells (HAEC) (Kohlhaas et al., 2011)

As was mentioned above, diabetes is related with hyperglycaemia and insulin resistance, which are conditions that stimulate the oxidative stress in vasculature. Furthermore, exposure of HUVEC to high extracellular concentrations of D-glucose increases the synthesis of dependent of NAD(P)H oxidase, which reacts with the NO to generate ONOO⁻, contributing to endothelial dysfunction (Sobrevia and González, 2009; González et al., 2015). Long-term incubation (24 h) of HUVEC with 25 mM D-glucose increases the transport of L-arginine and cGMP accumulation in a similar magnitude to that observed in HUVEC from pregnancies with gestational diabetes mellitus (Sobrevia et al., 1996, 1997). Increased transport of L-arginine in both chronic incubation with D-glucose and gestational diabetes has been linked to increased mRNA levels for hCAT-1 and eNOS activity (Vásquez et al., 2004, 2007). In HAEC, prolonged incubation (7 days) with 25 mM D-glucose induces decreased eNOS activity (determined by nitrite content) and lower abundance of the protein and mRNA level (Furfine et al., 1994). This effect is associated with decreased activity of eNOS promoter (Srinivasan et al., 2004). In HUVEC, the hyperglycaemic environment induces an increase in the abundance of the eNOS protein (Vásquez et al., 2007), an effect that would be associated with the activity of a signaling pathway involving the PI3K and Akt. It has also been shown that in BAEC, there is a reduced production of insulin-dependent NO when cells were incubated with high extracellular concentration of D-glucose, an effect that seems to depend on a signaling pathway involving the type 1 insulin receptor (IR-1), PI3K and the inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ) (Kim et al., 2006). Furthermore, increased production of cGMP induced by D-glucose in HUVEC is blocked by incubating the cells with 1 nM insulin (Sobrevia et al., 1997); and the incubation with 1 nM insulin (8 h) is sufficient to block the effect of D-glucose on the decrease of adenosine transport (Muñoz et al., 2006), an important vasoactive nucleoside (San Martín and Sobrevia, 2006). More recently, González et al. (2015) demonstrated that high extracellular concentration of D-glucose increases the expression of hCAT-1 and L-arginine transport, inducing high synthesis of NO associated with NADPH oxidase-dependent synthesis in HUVEC. On other hand, insulin (in normoglycaemic environment) increases L-arginine transport and NO synthesis without changes in levels, showing a physiological response that results in relaxation of umbilical vein (González et al., 2011). Interestingly, the effect of high D-glucose is associated with high contractile response to U46619 (thromboxane A2 analog) and hydrogen peroxide (H₂O₂). Co-incubation with insulin recovers the adequate response to vasoconstrictors and decreases the NADPH oxidase-dependent ROS (González et al., 2015). These mechanisms induced by high D-glucose could be responsible for endothelial dysfunction in diabetes, a scenario in which the L-arginine and NO convert from “good guys” to “bad guys” in company with high levels of ROS. In these conditions, insulin reduces the oxidative stress to improve bioavailability of NO, as long as the endothelial cell retains its capacity to respond appropriately to the hormone (Figure 1). In fact, in diabetic patients there is a significant reduction of forearm blood flow in response to insulin infusion, and an increase in L-arginine clearance (L-arginine incorporation to the tissue) during insulin infusion was 41% less in diabetic subjects compared to controls after adjusting for covariates age, BMI, MAP, and HDL cholesterol (Rajapakse et al., 2013). The data discussed in this section confirm the potential association between T2DM (and gestational diabetes), insulin resistance and endothelial dysfunction. Hence, further research must be focused on detailed mechanisms that regulate the cardiovascular actions of insulin in other states, such as hypertension and heart failure. Following this principle, in the second part of this article we review the effects of disturbances in cardiac insulin signaling.

Figure 1

Insulin regulation of cardiac function

Overview about action potential of cardiomyocytes

Normal mechanical function of the heart in mammals depends on proper electrical functioning, which is reflected in the sequential activation of pacemaker cells and subsequent electrical propagation through the ventricles. Coordinated electrical functioning of the heart is recorded by a surface electrocardiogram (ECG). Propagation activity and electromechanical coordination of ventricles also depends on coupling among cells, mediated by gap junctions (Kanno and Saffitz, 2001). Generation of action potential (AP) in myocardium results from sequential activation and inactivation of ion channels, which can lead input currents (Na⁺ and Ca²⁺) and an output repolarization currents (K⁺) (Figure 2) (Antzelevitch and Dumaine, 2002; Nerbonne and Kass, 2005).

Figure 2

AP differ in distinct regions of the heart, and contribute to the spreading of excitation way through the myocardium and the subsequent generation of normal heart beat (Kléber and Rudy, 2004). Changes in functional properties, or in the expression of ion channels in the myocardium, as a result of mutations (Antzelevitch, 2003) or myocardial diseases (Cesario et al., 2006), can lead to changes in the AP, synchronization or spread, including the heart's predisposition to potentially life-threatening arrhythmias (Akar et al., 2000; Casis et al., 2000; Casis and Echevarria, 2004). Given the clinical relevance of heart rhythm, it is of considerable interest to analyse the cellular and molecular mechanisms that contribute to the generation and maintenance of normal heart rhythm. Animal non-human studies suggests that small changes in time- and voltage-dependence properties of ion channels, in the myocardial sarcolemma, may have profound effects in both the action potentials time as well in the refractory period and rhythmicity (Delmar, 1992; Delisle et al., 2004).

In atrial myocytes, ventricular myocytes and Purkinje fibers, the onset of AP is fast (Phase 0) and given principally by voltage-dependent Na⁺ (Nav) channels activity (Fozzard, 2002). In contrast, in pacemaker cells of sino-atrial (SA) node (SAN) and atrio-ventricular (AV) node (AVN), this phase 0 is markedly slower. Phase 0 in Purkinje fibers and myocytes is followed by a transient repolarization (phase 1), reflecting Nav channel inactivation and the activation of the fast transient voltage-gated outward K⁺ current (Ito, f) (Niwa and Nerbonne, 2010). This transient repolarization, which can be quite prominent in Purkinje and ventricular cells, influences the shape and the time of the action potential plateau (phase 2). Plasma membrane depolarization also activates voltage-gated Ca²⁺ (Cav) currents, and the subsequent influx of Ca²⁺ through L-type Cav channels, during the phase 2 (plateau), triggering the excitation-contraction coupling in myocardium (Bers and Perez-Reyes, 1999). The driving force for K⁺ efflux is high during the plateau phase, and when Cav channels are inactivated, the outward K⁺ currents predominate, resulting in repolarization (phase 3). As a result, the voltage of plasma membrane returns to the resting potential. In contrast to Nav and Cav currents, there are multiple types of voltage-gated K⁺ (Kv) currents, as well as non-voltage-gated, inwardly rectifying K⁺ (Kir) currents (Figure 2 and Table 1). At least two types of transient outward currents, Itof and Itos, and several delayed rectifiers including IKr (IK rapid), IKs (IK slow), and IKur (IK ultra-rapid) have been distinguished (Brunet et al., 2004). The time- and voltage-dependent properties of Kv currents identified in myocytes from different species and/or from different regions of the heart present a remarkable similarity, suggesting that the same (or very similar) molecular entities contribute to the generation of each of the various types of Kv channels (Table 1) in different cells/species.

Table 1

Cardiac currents contributing to action potential repolarization.

A, atrial; P, Purkinje; V, ventricular; SAN, sinoatrial node; AVN, atrioventricular node. The dashed boxes are placed around current given different names in different species that likely are encoded by the same channel's subunit genes.

Voltage-dependent potassium channels

Based on biophysical differences and pharmacological sensitivities there are two main classes of Kv currents: transient outward currents (Ito) and delayed rectifier (IK) currents (Barry and Nerbonne, 1996; Nerbonne and Guo, 2002). The Ito currents are activated and rapidly inactivated on a depolarization stimuli (~−30 mV) and underlie the early phase (phase 1) of repolarization in ventricular and atrial cells in rat (Apkon and Nerbonne, 1991), mouse (Benndorf and Nilius, 1998), cat (Furukawa et al., 1990), rabbit (Hiraoka and Kawano, 1989), dog (Litovsky and Antzelevitch, 1998), and humans (Varró et al., 1993; Wettwer et al., 1993). The Ito currents influence Cav channel activation and the balance between inward and outward currents during phase 2. Cardiac IK currents are activated at similar plasma membrane potentials and present variable kinetics. These currents are determinant for the latter phase of repolarization that determine the diastolic potential (Barry and Nerbonne, 1996).

The two components of the Ito currents identified in the heart cell types show different kinetics of recovery (Xu et al., 1999). The Ito rapid current component (Ito fast, Itof) is recovered rapidly in the range of 60–100 ms (Patel and Campbell, 2005). In contrast, the slow component (Ito slow, Itos) recovers slowly with time constants in the order of seconds (Xu et al., 1999). Both are differentially expressed and contribute to heterogeneity of the action potential shape (Brunet et al., 2004).

Structurally, Kv channels are comprised of four α subunits that form the channel pore (MacKinnon, 1991), each subunit with six transmembrane segments (denoted S1–S6) including the voltage sensor S4 (Snyders, 1999), a single pore region between S5 and S6, and C- and N-terminal intracellular domains. The pore region works as a K⁺ selectivity filter (Doyle et al., 1998). In Kv1 to Kv4, the amino acids sequence at the N-terminal domain, which precedes S1, plays a critical role in the assembly Kvα subunit (Figure 3) (McKeown et al., 2008). Evidence suggests that Kv α-subunits of the Kv4 subfamily are responsible for a rapidly activating, inactivating, and recovering cardiac transient outward Kv channels referred to as Itof (Table 1). In rat and mouse ventricular myocytes exposed to antisense oligodeoxynucleotides targeted against Kv4.2 or Kv4.3, Itof density is reduced by < 50% (Fiset et al., 1997; Guo et al., 2002). Significant reductions in rat ventricular Itof density are also seen in cells exposed to an adenoviral construct encoding a truncated Kv4.2 subunit (Kv4.2ST) that functions as a negative dominant (Johns et al., 1997). In addition, it has been reported that Itof is eliminated in ventricular myocytes isolated from transgenic mice, expressing a pore mutant of Kv4.2, W362F (Barry et al., 1998). Taken together, these results demonstrate that members of the Kv4 subfamily underlie Itof in mouse and rat ventricles. Biochemical studies have also shown that Kv4.2 and Kv4.3 are associated in adult mouse ventricles, suggesting that functional ventricular Itof reflect the heteromeric assembly of the Kv4.2 and Kv4.3 α-subunits (Guo et al., 2002). In dog and human myocardium, however, Kv4.2 appears not to be expressed (Kong et al., 1998), suggesting that only Kv4.3 contributes to Itof, in larger mammals. Moreover, the genetic deletion of Kv4.2 abolishes Itof current, revealing a critical role of Kv4.2 channels in generating these currents in rodents (Guo et al., 2005).

Figure 3

Biophysical properties of slow transient outward myocardial Kv currents, referred as Itos, are different. Considerable evidence supports that myocardial Itos currents are encoded by the Kv1 α-subunit, Kv1.4. Heterologous expression of Kv1.4 yields slowly recovering (seconds), 4-aminopyridine (4-AP, Kv inhibitor) sensitive transient Kv currents (Tseng-Crank et al., 1990; Po et al., 1992; Comer et al., 1994; Wickenden et al., 1999) that closely resemble Itos (Fermini et al., 1992; Brahmajothi et al., 1999; Wang et al., 1999; Xu et al., 1999). In addition, expression of Kv1.4 has been demonstrated at the transcript level in rat (Tseng-Crank et al., 1990; Roberds and Tamkun, 1991; Wickenden et al., 1999), ferret (Brahmajothi et al., 1999), canine (Dixon et al., 1996), and human (Tamkun et al., 1991) hearts, and at the protein level in mouse, rat and ferret ventricles (London et al., 1998; Brahmajothi et al., 1999; Wickenden et al., 1999) and rabbit atrium (Wang et al., 1999). Direct support for this hypothesis was complemented on myocytes isolated from (Kv1.4^−∕−) mice with a targeted disruption in the kcna4 (Kv1.4) locus (London et al., 1998). Waveforms of outward currents in cells isolated from Kv1.4^−∕− ventricles are indistinguishable from those recorded in wild-type ventricular cells (Guo et al., 1999). In cells isolated from the interventricular septum from Kv1.4^−∕−, however, Itos is undetectable, thereby demonstrating that Kv1.4 underlies Itos (Guo et al., 1999).

Some studies suggest that additional subunits are required for the generation of cardiac Ito currents. Indeed, a number of molecularly diverse accessory subunits can modulate biophysical properties and cell surface expression of heterologously-expressed Kv4 channels (Guo et al., 2000; Abbott et al., 2007). Of these accessory subunits, only the cytoplasmic KChIP2 protein has been shown directly to be an essential component of myocardial Itof (Grubb et al., 2012). Co-expression of KChIP subunits dramatically increases the cell surface expression of Kv4 channels, Itos inactivation and markedly accelerates recovery (An et al., 2000). Also, KChIP2 co-immunoprecipitates with Kv 4.2 (and Kv4.3) α subunits in adult mouse ventricles (Guo et al., 2002) and the targeted deletion of the KChIP2 locus (kcnip2) abrogates ventricular Itof (Kuo et al., 2001). Interestingly, KChIP2 protein expression is dramatically reduced in Kv4.2^−∕− ventricles (Guo et al., 2005), suggesting that expression of the Kv4 and KChIP2 proteins are reciprocally regulated. Other regulatory subunit that colocalize with Kv4.2 is the MinK-related peptide (MiRP) (McCrossan and Abbott, 2004; Roepke et al., 2008). Although MiRP does not affect the densities of expressed Kv4.2-KChIP2 currents (Liu et al., 2008), targeted deletion of the gene encoding MiRP result in reduced (< 25%) ventricular Itof densities without changes in total or surface Kv4.2 expression (Roepke et al., 2008).

The ultra-rapid potassium current IKur is well expressed in the atria, where it contributes to repolarization (Amos et al., 1996). The molecular constituent of IKur is the Kv1.5 potassium channel (Boyle and Nerbonne, 1992; Wang et al., 1993). Direct experimental support for this hypothesis was provided with the demonstration that exposure to antisense oligonucleotide targeted against Kv1.5 selectively attenuates IKur in isolated adult human (Snyders et al., 1993; Feng et al., 1997) and rat atrial myocytes (Bou-Abboud and Nerbonne, 1999). The important physiological role for Kv1.5 in human atria is suggested by the finding that IKur densities and Kv1.5 protein expression are reduced markedly in atria of patients with chronic atrial fibrillation (Van Wagoner et al., 1997). Although, IKur has predominantly been reported in atria, it has also been suggested to play a role in canine and human ventricles (Nielsen et al., 2007; Sridhar et al., 2007; Calloe et al., 2010).

Insulin regulation of cardiac electrical function

Insulin has a direct effect in cardiomyocytes, in glucose transport and oxidation, glycolysis, glycogen and protein synthesis (Abel, 2004; Bertrand et al., 2008). In vivo, many of insulin's effects on cardiac function and metabolism are related to systemic responses such as an increment in peripheral and coronary vasodilatation, and sodium and water intake by the kidney (Muniyappa et al., 2007).

Insulin is a key regulator of cardiac growth as reported in studies carried out in cardiac insulin receptor knockout (CIRKO) mice. In this study, the cardiac index was reduced by 22–28%, possibly due to a decrease in myocyte size rather than a reduction in cell number (Belke et al., 2002). The role of insulin in cell size regulation is supported by studies in Drosophila with disrupted homolog of vertebrate insulin signaling, were the knock-out model for IRS, had less than half the size of wild-type flies, owing to fewer and smaller cells (Böhni et al., 1999). In experimental mice with targeted deletion of IRS-1 or IRS-2, there has been evidence of a reduction in postnatal cardiac size (Araki et al., 1994), which is indicative of conserved roles for insulin signaling in the determination of cardiac growth. Inhibition of PI3K function in mouse heart using a negative dominant transgene, results in a similar phenotype generated in CIRKO mice (Shioi et al., 2000). Negative dominant PI3K transgenic mice showed 16% reduction in cardiac index and myocyte surface area reduction of 18% (Belke et al., 2002). Thus, impaired PI3K activity represents a mechanism that explains the cardiac size phenotype in CIRKO mice.

In addition, insulin could increase cardiac contractility, affecting cardiac output, and mediates the cellular hypertrophy and generates an antiapoptotic effect on cardiomyocytes by activating other intermediary intracellular signaling pathways (Belke et al., 2002). Changes in these pathways and in the pathologic processes linked to status of insulin deficiency or insulin resistance could contribute to an increased risk of cardiac hypertrophy, pathological remodeling of the left ventricle and heart failure, among others (Cesario et al., 2006).

Diverse evidences suggests that the stimulatory effect of insulin involves K⁺ channel protein synthesis, which is responsible for maintaining both Ito and IKur currents; although it is proposed that the hormone regulates differentially these two currents (Shimoni et al., 1998; Rozanski and Xu, 2002; Lengyel et al., 2007; Torres-Jacome et al., 2013). In a recent review, Ballou et al. collected and summarized several studies that shows that PI3K signaling regulates many aspects of proteins involved in AP in the heart, including protein expression, trafficking and gating Nav1.5, Kv11.1, Kv7.1, and Cav1.2 in cardiomyocytes. This evidence comes from studies where drugs that inhibit PI3K signaling cause QT prolongation, but the role of PI3K in transcriptional regulation of genes in cardiomyocytes is relatively unexplored (Ballou et al., 2015).

However, a study of isolated cardiomyocytes from T1DM mice induced by STZ and treated with wortmannin (inhibitor of PI3K) prior to incubation with insulin, showed that insulin is still able to restore the densities of Ito currents without effect on other potassium currents (Ui et al., 1995). This indicates that this hormone could not induce its effects through PI3K pathway in T1DM (Shimoni et al., 1998). Insulin stimulates another important signaling pathway, MAPK/ERK, which can lead to cell proliferation and protein synthesis (Guo, 2014); furthermore, its activation can be blocked by PD98059, a specific inhibitor of the phosphorylation of ERK1/2 (Lazar et al., 1995). In isolated cardiomyocytes from T1DM rats treated with PD98059 (30 min) prior to the addition of insulin, blockage is perceived in the insulin-dependent return of the densities of potassium Ito currents (Shimoni et al., 1998). These results suggest that the effects on the maintenance of these currents and their respective channels occur in a MAP-kinase dependent process (Shimoni et al., 1998).

Cardiac disease in diabetes mellitus

Studies have found that diabetic patients have an increased risk of CVD (Gregg et al., 2014). Common complications are acute myocardial infarction (181.5 events/1000 people/year) and stroke (126.2 events/1000 people/year; Bethel et al., 2007). In a cohort of geriatric American adults with T2DM between 2004 and 2010, cardiovascular complications have the highest incidence, followed by eye disease and hypoglycaemic events (Huang et al., 2014). The presence of diabetes is associated with a high risk of cardiac failure (Aneja et al., 2008), and is present in the 75% of patients with idiopathic dilated cardiomyopathy (Bertoni et al., 2003). The “Framingham Heart” Study (Kannel and McGee, 1979) showed that the incidence of heart failure is 2 and 5 times higher for diabetic men and women, respectively. Diabetic patients with macrovascular complications showed a strong association with cardiomyopathy, and its association is well correlated with the duration and severity of hyperglycaemia (Poornima et al., 2006).

Diabetic cardiomyopathy

DM affects cardiac structure and function, which under certain conditions can lead to a condition called DCM. Rubler et al. described this condition first in 1972 and defined it as “ventricular dysfunction that occurs independently of coronary artery disease and hypertension” (Rubler et al., 1972). In addition, DCM is characterized by diastolic dysfunction, which becomes more apparent in presence of hypertension or myocardial ischemia (Fang et al., 2004). In humans, the DCM is also characterized by diastolic dysfunctions, which precede the development of systolic dysfunction (Liu et al., 2001). These findings also could be found in patients with T2DM, where diastolic dysfunction affected 30% of the patients (Boudina and Abel, 2007).

The effects of DCM lead to cardiomegaly, left ventricular dysfunction, ventricular electrical remodeling and symptoms of congestive heart failure (Casis et al., 2000). The resulting electrophysiological changes contribute to an increase in the incidence of cardiac arrhythmias and sudden death (Casis et al., 2000). Electrical changes have been associated with the surface ECG abnormalities, including T and QT wave prolongation (Casis et al., 2000; Casis and Echevarria, 2004).

Insulin resistance in the heart is a factor that contributes significantly to DCM (Mandavia et al., 2013). Therefore, it is important to distinguish between the secondary effects to environmental disturbances in states of insulin resistance and specific changes that occur in the signaling pathways that are intrinsic to heart tissue. These effects determine, among others, changes in cardiomyocyte AP as might be the extension of repolarization phase (Lengyel et al., 2007), and thus infer the pathophysiological mechanism that would play insulin on heart function.

Morphological changes in the ventricular action potential

The morphology of AP is clearly altered in T1DM and T2DM, showing a prolonged QT in myocytes isolated from STZ models in either, mice (Magyar et al., 1992; Casis et al., 2000) or rabbits (Torres-Jacome et al., 2013). AP duration in cells stimulated at 1 Hz increases in isolated cells from diabetic mice (Casis et al., 2000). These cells shown, phase 1 (early repolarization) less pronounced and a longer phase 2 (plateau). Otherwise, the resting membrane potential and the AP amplitude were unchanged (Casis et al., 2000). Moreover, T2DM models (db/db mice, a leptin receptor mutant that develops obesity, diabetes, hyperinsulinemia and increased levels of triglycerides and fatty acids; Buchanan et al., 2005) shown similar prolongation of action potentials (Figure 4) (Shimoni, 2001).

Figure 4

Prolongation of action potentials is due to, at less in part, by a decrease in the output repolarizing currents (Ito and IK) (Shimoni et al., 1999, 2004; Qin et al., 2001). The amplitude of the currents (Ito and IK) are reduced in myocytes isolated from T1DM murine models (Torres-Jacome et al., 2013). In addition, myocytes isolated from db/db mice (12th week of age), as a T2DM model, exhibit a sustained attenuation of the output currents compared to the db/+ mouse (Shimoni, 2001; Shimoni et al., 2004). Therefore, despite the dramatically different levels of insulin circulating in the STZ diabetic rat and db/db mouse, the changes of action potential and ventricular output K⁺ currents are similar, suggesting that these effects could be generated by an impaired ligand-receptor coupling or absence of insulin signaling pathway (Shimoni et al., 2004).

Despite the total output currents of K⁺ are impaired (Figure 4), is necessary to determine which one is most relevant electrical change. In dogs treated with alloxan (a toxic glucose analog that destroys the β-pancreatic cells) to induce T1DM, after 8 weeks, were evaluated the different currents contribution to the AP through voltage-clamp experiments. In this case, no changes were found in neither amplitude nor voltage-dependent IKr and ICa activation currents. Conversely, the amplitude of the Ito and IKur currents significantly decreased by 69.3 and 54.6% in myocyte cells isolated from diabetic models, respectively. In an effort to clarify the effects of insulin, after a week from developed diabetes, dogs were treated with insulin (0.5–1.0 IU/kg day-1s.c), and an increase in current density was evident only in the Ito and IKur currents (Lengyel et al., 2007). This result is consistent with findings obtained from myocytes isolated from hearts of diabetic mice (STZ model) incubated with insulin, in which the amplitudes of these currents were restored (Magyar et al., 1992; Xu et al., 1996, 2002; Shimoni et al., 1998).

Several animal models have been used to characterize the effects of diabetes on the heart (Shimoni et al., 2004; Boudina and Abel, 2010) and include a variety of systemic effects (Bugger and Abel, 2009). Diminished glucose oxidation rates in cardiomyocytes occur as early as 48 h after the induction of diabetes by STZ treatment, which is reversed by insulin treatment (Chen et al., 1984). Insulin-stimulated cardiac glucose uptake and their utilization are also impaired in type 2 diabetic hearts (Mazumder et al., 2004). Furthermore, in hyperinsulinemic animal models of T2DM, such as the Zucker diabetic rat, the impaired insulin signal transduction in cardiac muscle (Kolter et al., 1997) is also associated with diminished glucose utilization and increased fatty acid utilization in the heart (Chatham, 2001). In all of these models it is difficult to separate the relative contribution of intrinsic defects in cardiomyocyte insulin signaling from the conditions generated by the altered systemic metabolism, such as hyperglycaemia and hyperlipidaemia.

The cardiac-specific insulin receptor knockout (CIRKO) mice model, development by cre/loxP recombination to specifically inactivate insulin signaling in cardiomyocytes in vivo, preserve insulin signaling in other cells such as endothelial cells, VSMC, and liver and skeletal muscle cells (Brüning et al., 1998; Abel et al., 1999) and let to investigate the specific role of impaired cardiac insulin signaling without the additional conditions associated to systemic metabolic perturbations (Belke et al., 2002). CIRKO mice develop contractile dysfunction but not heart failure, associated with decreased glucose and fatty acid oxidation (Belke et al., 2002). Also develop mitochondrial dysfunction, with an increased mitochondrial superoxide production, and display fatty acid-induced mitochondrial uncoupling (Boudina et al., 2009). Likewise, CIRKO mice represent a useful model to dissect the mechanisms and the effects of insulin in the heart, in the absence of systemic effects of insulin deficiency, or the additional conditions associated to systemic effects of insulin treatment as occur in many models of diabetes.

Effects of diabetes on gene expression of Kv channels

Decreased of outward currents induced by diabetes conditions may be attributed to deficient protein expression (Howarth et al., 2009), changes in biophysical properties, or both (Lopez-Izquierdo et al., 2014). Until now, there is no difference in voltage dependence of inactivation, inactivation kinetics, or recovery from inactivation state. It is suggested that these effects are explained by an abnormal protein expression (Lopez-Izquierdo et al., 2014).

The study of the cardiac gene expression by RT-PCR considering the genes: kcnd2 and kcnd3 encoding the Ito α-subunit Kv4.2 and Kv4.3, respectively (Frank-Hansen et al., 2005); kcne2 encoding to MiRP1, Ito and IKs β-subunit (Roepke et al., 2008), on tissue extracted from left ventricles of mice with STZ-induced diabetes showed significant reductions of ~80% in the expression of kcnd2 and kcne2, whereas no significant differences were shown for kcnd3 (Howarth et al., 2009). These results were replicated in CIRKO mice, where KChIP2, Kv4.2 accessory subunit had about 50% reduction. Therefore, Kv4.2 and its assembly with specific accessory subunits such KChIP2 and MiRP1, would be relevant in maintaining transient K⁺ current, mainly in its fast component (Itof) (Lopez-Izquierdo et al., 2014).

Studies in animal models of diabetes also reveal a reduction in the mRNA and protein levels of the components of Itof (Qin et al., 2001). Based on the analysis of protein levels of ion channels evaluated by western blot obtained for CIRKO mice left ventricle, show a reduction of ~50% in the abundance of Kv4.2 and Kv1.5 (Lopez-Izquierdo et al., 2014). In contrast, other studies using a T1DM rat or CIRKO mice model, report a reduction in Kv4.2 protein expression, but not for the Kv4.3 channel, were neither the messenger nor protein expression were down-regulated (Kääb et al., 1998; Nishiyama et al., 2001). KChIP decreased by 40% when compared to the control group (Lopez-Izquierdo et al., 2014). Furthermore, immunofluorescence analysis shows a reduction of immunoreactivity for Kv4.2, Kv4.3, and Kv1.5 protein, in isolated ventricular cardiomyocytes from T1DM models vs. healthy controls, and no changes of Kv2.1 (IKr determining protein) were found (Torres-Jacome et al., 2013). Moreover, in extracted tissue from ventricles of diabetic animals evaluated by immunohistochemistry, a reduction has been shown in the number of cardiomyocytes with immunopositive reactivity to Kv4.2 and MiRP1 (IKur β-subunit), consistent with the reduced expression genes that encode them (Howarth et al., 2009). Therefore, a reduction in Kv4.2, Kv1.5 messenger and protein provides an explanation for the reduced Ito and IKur currents, observed in impaired insulin signaling conditions, respectively. At the same time, interaction with accessory subunits, such as KChiP2 and MiRP-1, would be relevant to the maintenance of these currents (Grubb et al., 2012).

In addition, the results previously mentioned suggest a regulatory role of insulin in the expression of different potassium channels in diabetic cardiomyocytes. Incubation of isolated myocytes with insulin can recover the protein expression of Kv4.2 and Kv1.5 channels, and also restores the amplitude of potassium currents when tested after 3, 4, 5, and 6 h incubation (Shimoni et al., 1998). In the same way, the use of protein synthesis blockers, such as cycloheximide, blocks these currents' recovery (Rozanski et al., 1998). Furthermore, the effect of insulin depends on the integrity of the cytoskeleton, hence protein traffic inhibitors, as cytochalasin D, are able to attenuate this effect (Shimoni et al., 1999; Yang et al., 2002). Presumably, it is necessary that newly synthesized channels can effectively translocate to the cell membrane to maintain these specific repolarizing currents.

Clinical implications

Insulin is a hormone with pleiotropic physiological functions, so it is normal to conclude that deterioration of insulin signaling also has pleiotropic dysfunctions. In this review, we discuss two main mechanism that govern the cardiovascular physiology, one mechanism in endothelial cell related with L-arginine transport and NO bioavailability, and a second main mechanism related with the regulation of Kv channels on cardiomyocytes.

The physiological role of NO is well known in human vasculature, so the largest contribution of this review is the establishment that insulin resistance is closely related with potential reduction of hCAT-1 expression and/or activity in endothelial cells. Reduction of L-arginine transport is a primarily cause of endothelial dysfunction and induces a reduction of NO synthesis due to restriction of substrate availability for eNOS. Cardiovascular pathologies associated to insulin resistance are well documented, and we propose that the significant reduction of L-arginine transport mediated by lower expression and/or alteration of plasma membrane localization of the transporter could be a link between the impairment of insulin signaling and vascular disease. Clinical evidence shows that the forearm L-arginine uptake is reduced in subjects with essential hypertension or with family history of hypertension. In peripheral blood mononuclear cells (PBMCs) isolated from the same patients, a reduction was seen of V_max of L-arginine transport and lower sensitivity to Ach-dependent vasodilatation, parameter that was reverted by co-infusion of L-arginine (Schlaich et al., 2004). Also a reduction in agonist-induced blood flow was observed in response to insulin in patients with T2DM, an alteration that is associated to lower capacity of transport of L-arginine and NO synthesize (Rajapakse et al., 2013). Additionally, in CHF patients it is determined that there is a reduced capacity for transport of L-arginine from plasma to the tissues with reduction of transcardiac fractional extraction of L-arginine and lower expression of hCAT-1 in myocardial tissue, without changes in hCAT-2B expression. Also the transcardiac L-citrulline flux, as a parameter of NO synthesis in heart, is decreased in CHF patients (Kaye et al., 2002). These data indicate the presence of an abnormal L-arginine transport in CHF, suggesting a shared mechanism between endothelial dysfunction and heart disease, related with hCAT-1 down-regulation and impairment of NO synthesis.

Altogether, this information demonstrates that there is a positive feedback mechanism between insulin secretion, insulin signaling, L-arginine/NO pathway, and cardiac function that is disrupted in pathophysiological conditions such as metabolic syndrome, insulin resistance and diabetes.

In regards to the physiological role of insulin in the regulation of Kv channels and their association with cardiac electrical function specifically, this relationship would be given by an altered intracellular signaling in a similar way to the pathological processes involved in diabetes mellitus (Casis and Echevarria, 2004). Diabetic patients show electrocardiographic changes associated with a high incidence of cardiac arrhythmias (Veglio et al., 1999, 2002a,b, 2004). Specifically, long QT syndromes (duration of ventricular depolarization and repolarization of the myocardium) have been reported as a result of an increase in the time of the ventricular action potential. This phenomenon has been linked to a three-fold increased risk of sudden cardiac death (Straus et al., 2006). Even more, studies have shown a significantly increase in relative death risk for subjects with QTc (QTc, heart rate-corrected QT interval) longer than 0.43–0.44 s (Brown et al., 2001). This relationship has been shown for all cause mortality, cardiac mortality, and sudden death (Festa et al., 2000).

Prevalence of QTc prolongation has been evaluated in different cohorts of diabetic subjects (Veglio et al., 1999, 2002a,b) and in the National Health and Nutrition Examination Survey III (NHANES III) population (Brown et al., 2001; Zhang et al., 2011). In T1DM patients, the prevalence of an abnormally prolonged, corrected QT was 16% in the whole population, 11% in males and 21% in females. QTc in insulin-dependent diabetic female patients is longer than in male patients, even in the absence of diabetic complications known to increase the risk of corrected QT prolongation (Veglio et al., 1999). While in T2DM patients, prevalence of increased QTc duration was 25.8%, with no sex differences, showing a considerably high prevalence of increased QTc and their association with Coronary Heart Disease (Veglio et al., 2002a,b). Finally, in the NHANES III survey, the prevalence of QTc prolongation in diabetic subjects was nearly twice that of non-diabetic subjects (Brown et al., 2001; Zhang et al., 2011).

Different studies explain the action potential prolongation as a response to a reduction of repolarizing K⁺ currents, in cardiomyocytes isolated from type 1 to 2 diabetic models (Magyar et al., 1992; Shimoni et al., 1994; Casis et al., 2000; Shimoni, 2001; Torres-Jacome et al., 2013). To examine the effects of impaired insulin signaling on these electrophysiological changes, recent studies have measured the electrocardiographic activity in anesthetized CIRKO mice, in order to assess the effect of the lack of cardiomyocyte specific insulin receptor (Lopez-Izquierdo et al., 2014). When was compared the electrocardiographic recordings from CIRKO mice vs. control mice, it has been demonstrated a significant prolongation of the QRS, QT, and QTc intervals (Lopez-Izquierdo et al., 2014).

The specific contribution of impaired insulin signaling in gene expression for cardiac Kv channels, lead to a QT interval prolongation in experimental models (Figure 5) (Howarth et al., 2009). This is similar to the findings that were reported for diabetic patients (Veglio et al., 2002a,b). These results are independent of the systemic metabolic changes that join the disease.

Figure 5

Concluding remarks

In summary, insulin has general effects on all tissues and a strong relationship with cardiovascular function. Specifically, through experimental models of impaired intracellular signaling, which occurs in pathological conditions such as diabetes, it is possible to elucidate the regulatory effects that tie this particular ligand to the vascular and cardiac function.

Diabetes involves a series of prevalent cardiovascular complications such as DCM, a disease that appears as relevant for studying the effects of insulin resistance. This is because it includes a number of pathophysiological events, which include the ventricular electric remodeling.

Insulin plays an important role in maintaining the current repolarizing, specifically the Ito and IKur components, which determine the appropriate action potential in ventricular cells. This regulation is achieved through genes and proteins expression, which determine the Kv4.2 and Kv1.5 α subunits, β subunits and KChIP2 and MiRP1 composition, in a Ras/MAP Kinase signaling pathway-mediated process (Figure 5).

Outside of metabolic function, it is also evidenced that insulin, through the lack of its signaling pathways, plays a regulatory role in the cardiac electrical activity through voltage-dependent potassium channels and can produce electrocardiographic changes, such as QT prolongation, and increased risk of sudden death in diabetic patients.

Funding

This work was supported by Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT 11100192, 1150377) and Vicerrectoría de Investigación y Desarrollo, Universidad de Concepción (VRID-Asociativo 213.A84.014-1.0), Chile.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

• 1

  AbbottG. W.XuX.RoepkeT. K. (2007). Impact of ancillary subunits on ventricular repolarization. J. Electrocardiol.40, S42–S46. 10.1016/j.jelectrocard.2007.05.021

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 2

  AbelE. D. (2004). Glucose transport in the heart. Front. Biosci.9, 201–215. 10.2741/1216

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 3

  AbelE. D.KaulbachH. C.TianR.HopkinsJ. C.DuffyJ.DoetschmanT.et al. (1999). Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J. Clin. Invest.104, 1703–1714. 10.1172/JCI7605

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 4

  AkarF. G.LauritaK. R.RosenbaumD. S. (2000). Cellular basis for dispersion of repolarization underlying reentrant arrhythmias. J. Electrocardiol.33, 23–31. 10.1054/jelc.2000.20313

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 5

  AmosG. J.WettwerE.MetzgerF.LiQ.HimmelH. M.RavensU. (1996). Differences between outward currents of human atrial and subepicardial ventricular myocytes. J. Physiol.491, 31–50. 10.1113/jphysiol.1996.sp021194

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 6

  AnW. F.BowlbyM. R.BettyM.CaoJ.LingH. P.MendozaG. (2000). Modulation of A-type potassium channels by a family of calcium sensors. Nature403, 553–556. 10.1038/35000592

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 7

  AnejaA.TangW. H.BansilalS.GarciaM. J.FarkouhM. E. (2008). Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am. J. Med.121, 748–757. 10.1016/j.amjmed.2008.03.046

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 8

  AntzelevitchC. (2003). Molecular genetics of arrhythmias and cardiovascular conditions associated with arrhythmias. J. Cardiovasc. Electrophysiol. 14, 1259–1272. 10.1046/j.1540-8167.2003.03316.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 9

  AntzelevitchC.DumaineR. (2002). Section 2: Electrical heterogeneity in the heart: physiological, pharmacological and clinical implications, in Handbook of Physiology. The Cardiovascular System. The Heart. Vol. I, ed SolaroP. F. (Bethesda, MD: Am. Physiol. Soc.), 654–692.

  • Google Scholar

• 10

  ApkonM.NerbonneJ. M. (1991). Characterization of two distinct depolarization-activated K⁺ currents in isolated adult rat ventricular myocytes. J. Gen. Physiol.97, 973–1011. 10.1085/jgp.97.5.973

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 11

  ArakiE.LipesM. A.PattiM. E.BrüningJ. C.HaagB.JohnsonR. S.et al. (1994). Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature372, 186–190. 10.1038/372186a0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 12

  BallouL. M.LinR. Z.CohenI. S. (2015). Control of cardiac repolarization by phosphoinositide 3-kinase signaling to ion channels. Circ. Res.116, 127–137. 10.1161/CIRCRESAHA.116.303975

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 13

  BaronA. D. (2002). Insulin resistance and vascular function. J. Diabetes Complications16, 92–102. 10.1016/S1056-8727(01)00209-4

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 14

  BaronA. D.BrechtelG.JohnsonA.FinebergN.HenryD. P.SteinbergH. O. (1994). Interactions between insulin and norepinephrine on blood pressure and insulin sensitivity. Studies in lean and obese men. J. Clin. Invest. 93, 2453–2462. 10.1172/JCI117254

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 15

  BaronA. D.Brechtel-HookG.JohnsonA.HardinD. (1993). Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension21, 129–135. 10.1161/01.HYP.21.2.129

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 16

  BaronA. D.LaaksoM.BrechtelG.HoitB.WattC.EdelmanS. V. (1990). Reduced postprandial skeletal muscle blood flow contributes to glucose intolerance in human obesity. J. Clin. Endocrinol. Metab. 70, 1525–1533. 10.1210/jcem-70-6-1525

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 17

  BarryD. M.NerbonneJ. M. (1996). Myocardial potassium channels: electrophysiological and molecular diversity. Annu. Rev. Physiol.58, 363–394. 10.1146/annurev.ph.58.030196.002051

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 18

  BarryD. M.XuH.SchuesslerR. B.NerbonneJ. M. (1998). Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 α subunit. Circ. Res.83, 560–567. 10.1161/01.RES.83.5.560

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 19

  BelkeD.BetuingS.TuttleM.GraveleauC.YoungM.AbelE.et al. (2002). Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J. Clin. Invest.109, 629–639. 10.1172/JCI0213946

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 20

  BenndorfK.NiliusB. (1998). Properties of an early outward current in single cells of the mouse ventricle. Gen. Physiol. Biophys.7, 449–466.

  • Pubmed Abstract
  • Google Scholar

• 21

  BersD. M.Perez-ReyesE. (1999). Ca²⁺ channels in cardiac myocytes: structure and function in Ca²⁺ influx and intracellular Ca²⁺ release. Cardiovasc. Res.42, 339–360. 10.1016/S0008-6363(99)00038-3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 22

  BertoniA. G.TsaiA.KasperE. K.BrancatiF. L. (2003). Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care26, 2791–2795. 10.2337/diacare.26.10.2791

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 23

  BertrandL.HormanS.BeauloyeC.VanoverscheldeJ. L. (2008). Insulin signalling in the heart. Cardiovasc. Res.79, 238–248. 10.1093/cvr/cvn093

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 24

  BethelM. A.SloanF. A.BelskyD.FeinglosM. N. (2007). Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. Arch. Intern. Med.167, 921–927. 10.1001/archinte.167.9.921

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 25

  BöhniR.Riesgo-EscovarJ.OldhamS.BrogioloW.StockerH.AndrussB. F.et al. (1999). Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell97, 865–875. 10.1016/S0092-8674(00)80799-0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 26

  Bou-AbboudE.NerbonneJ. M. (1999). Molecular correlates of the calcium-independent, depolarization-activated K⁺ currents in rat atrial myocytes. J. Physiol.517, 407–420. 10.1111/j.1469-7793.1999.0407t.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 27

  BoudinaS.AbelE. D. (2007). Diabetic cardiomyopathy revisited. Circulation115, 3213–3223. 10.1161/CIRCULATIONAHA.106.679597

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 28

  BoudinaS.AbelE. D. (2010). Diabetic Cardiomyopathy, causes and effects. Rev. Endocr. Metab. Disord.11, 31–39. 10.1007/s11154-010-9131-7

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 29

  BoudinaS.BuggerH.SenaS.O'NeillB. T.ZahaV. G.IlkunO.et al. (2009). Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation19, 1272–1283. 10.1161/CIRCULATIONAHA.108.792101

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 30

  BoyleW. A.NerbonneJ. M. (1992). Two functionally distinct 4-amino-pyridine-sensitive outward K⁺ currents in rat atrial myocytes. J. Gen. Physiol.100, 1041–1067. 10.1085/jgp.100.6.1041

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 31

  BrahmajothiM. V.CampbellD. L.RasmussonR. L.MoralesM. J.TrimmerJ. S.NerbonneJ. M. (1999). Distinct transient outward potassium current (Ito) phenotypes and distribution of fast-inactivating potassium channel α-subunits in ferret left ventricular myocytes. J. Gen. Physiol.113, 581–600. 10.1085/jgp.113.4.581

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 32

  BrownD. W.GilesW. H.GreenlundK. J.ValdezR.CroftJ. B. (2001). Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the third national health and nutrition examination survey. J. Cardiovasc. Risk8, 227–233. 10.1177/174182670100800407

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 33

  BrunetS.AimondF.LiH.GuoW.EldstromJ.NerbonneJ. M.et al. (2004). Heterogeneous expression of repolarizing, voltage-gated K⁺ currents in adult mouse ventricles. J. Physiol.559, 103–120. 10.1113/jphysiol.2004.063347

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 34

  BrüningJ. C.MichaelM. D.WinnayJ. N.HayashiT.HörschD.AcciliD.et al. (1998). A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell2, 559–569. 10.1016/S1097-2765(00)80155-0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 35

  BuchananJ.MazumderP.HuP.ChakrabartiG.RobertsM.AbelE. D.et al. (2005). Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology146, 5341–5349. 10.1210/en.2005-0938

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 36

  BuggerH.AbelE. D. (2009). Rodent models of diabetic cardiomyopathy. Dis. Models Mech.2, 454–466. 10.1242/dmm.001941

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 37

  CaiS.KhooJ.MussaS.AlpN. J.ChannonK. M. (2005). Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation. Diabetologia48, 1933–1940. 10.1007/s00125-005-1857-5

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 38

  CalloeK.SoltysinskaE.JespersenT.LundbyA.AntzelevitchC.OlesenS. P.et al. (2010). Differential effects of the transient outward K⁺ current activator NS5806 in the canine left ventricle. J. Mol. Cell. Cardiol.48, 191–200. 10.1016/j.yjmcc.2009.07.017

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 39

  CariappaR.Heath-MonnigE.FureszT. C.KamathS. G.SmithC. H. (2002). Stable polarized expression of hCAT-1 in an epithelial cell line. J. Membr. Biol.186, 23–30. 10.1007/s00232-001-0133-y

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 40

  CasanelloP.EscuderoC.SobreviaL. (2007). Equilibrative nucleoside (ENTs) and cationic amino acid (CATs) transporters: implications in foetal endothelial dysfunction in human pregnancy diseases. Curr. Vasc. Pharmacol.5, 69–84. 10.2174/157016107779317198

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 41

  CasisO.EchevarriaE. (2004). Diabetic cardiomyopathy: electromechanical cellular alterations. Curr. Vasc. Pharmacol. 2, 237–248. 10.2174/1570161043385655

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 42

  CasisO.GallegoM.IriarteM.Sánchez-ChapulaJ. A. (2000). Effects of diabetic cardiomyopathy on regional electrophysiologic characteristics of rat ventricle. Diabetología43, 101–109. 10.1007/s001250050013

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 43

  CesarioD. A.BrarR.ShivkumarK. (2006). Alterations in ion channel physiology in diabetic cardiomyopathy. Endocrinol. Metab. Clin. North. Am.35, 601–610. 10.1016/j.ecl.2006.05.002

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 44

  ChathamJ. C. (2001). The impact of type 2 diabetes on the regulation of cardiac energy metabolism and function. J. Mol. Cell. Cardiol.33, A153. 10.1016/S0022-2828(01)90587-5

  • CrossRef
  • Google Scholar

• 45

  ChenV.IanuzzoC. D.FongB. C.SpitzerJ. J. (1984). The effects of acute and chronic diabetes on myocardial metabolism in rats. Diabetes33, 1078–1084. 10.2337/diab.33.11.1078

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 46

  ClossE. I.BoisselJ. P.HabermeierA.RotmannA. (2006). Structure and function of cationic amino acid transporters (CATs). J. Membr. Biol. 213, 67–77. 10.1007/s00232-006-0875-7

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 47

  ClossE. I.GräfP.HabermeierA.CunninghamJ. M.FörstermannU. (1997). Human cationic amino acid transporters hCAT-1, hCAT-2A, and hCAT-2B: three related carriers with distinct transport properties. Biochemistry36, 6462–6468. 10.1021/bi962829p

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 48

  ComerM. B.CampbellD. L.RasmussonR. L.LamsonD. R.MoralesM. J.ZhangY. (1994). Cloning and characterization of an Ito-like potassium channel from ferret ventricle. Am. J. Physiol.267, H1383–H1395.

  • Pubmed Abstract
  • Google Scholar

• 49

  CoppsK. D.WhiteM. F. (2012). Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia55, 2565–2582. 10.1007/s00125-012-2644-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 50

  CosentinoF.EtoM.De PaolisP.van der LooB.BachschmidM.UllrichV.et al. (2003). High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation107, 1017–1023. 10.1161/01.CIR.0000051367.92927.07

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 51

  DelisleB. P.AnsonB. D.RajamaniS.JanuaryC. T. (2004). Biology of cardiac arrhythmias: ion channel protein trafficking. Circ. Res.94, 1418–1428. 10.1161/01.RES.0000128561.28701.ea

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 52

  DelmarM. (1992). Role of potassium currents on cell excitability in cardiac ventricular myocytes. J. Cardiovasc. Electrophysiol.3, 474–486. 10.1111/j.1540-8167.1992.tb00990.x

  • CrossRef
  • Google Scholar

• 53

  DelmarM. (2004). Role of potassium currents on cell excitability in cardiac ventricular myocytes. J. Cardiovasc. Electrophysiol. 3, 474–486. 10.1111/j.1540-8167.1992.tb00990.x

  • CrossRef
  • Google Scholar

• 54

  DevésR.BoydC. A. (1998). Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol. Rev.78, 487–545.

  • Pubmed Abstract
  • Google Scholar

• 55

  DixonJ. E.ShiW.WangH. S.McDonaldC.YuH.WymoreR. S. (1996). Role of the Kv4.3, K⁺ channel in ventricular muscle. A molecular correlate for the transient outward current. Circ. Res.79, 659–668. 10.1161/01.RES.79.4.659

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 56

  DoyleD. A.Morais CabralJ.PfuetznerR. A.KuoA.GulbisJ. M.CohenS. L.et al. (1998). The structure of the potassium channel: molecular basis of K⁺ conduction and selectivity. Science280, 69–77. 10.1126/science.280.5360.69

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 57

  FangZ. Y.PrinsJ. B.MarwickT. H. (2004). Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr. Rev. 25, 543–567. 10.1210/er.2003-0012

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 58

  FengJ.WibleB.LiG. R.WangZ.NattleS. (1997). Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K⁺ current in cultured adult human atrial myocytes. Circ. Res.80, 572–579. 10.1161/01.RES.80.4.572

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 59

  FerminiB.WangZ.DuanD.NattelS. (1992). Differences in rate dependence of transient outward current in rabbit and human atrium. Am. J. Physiol.263, H1747–H1754.

  • Pubmed Abstract
  • Google Scholar

• 60

  FestaA.D'AgostinoR.Jr.RautaharjuP.MykkänenL.HaffnerS. M. (2000). Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am. J. Cardiol.86, 1117–1122. 10.1016/S0002-9149(00)01170-X

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 61

  FisetC.ClarkR. B.ShimoniY.GilesW. R. (1997). Shal-type channels contribute to the Ca²⁺-independent transient outward K⁺ current in rat ventricle. J. Physiol.500, 51–64. 10.1113/jphysiol.1997.sp021998

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 62

  FozzardH. A. (2002). Cardiac sodium and calcium channels: a history of excitatory currents. Cardiovasc. Res.55, 1–8. 10.1016/S0008-6363(02)00407-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 63

  Frank-HansenR.LarsenL. A.AndersenP.JespersgaardC.ChristiansenM. (2005). Mutations in the genes KCND2 and KCND3 encoding the ion channels Kv4.2 and Kv4.3, conducting the cardiac fast transient outward current (Ito, f), are not a frequent cause of long QT syndrome. Clin. Chim. Acta351, 95–100. 10.1016/j.cccn.2004.08.017

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 64

  FurfineE. S.HarmonM. F.PaithJ. E.KnowlesR. G.SalterM.KiffR. J.et al. (1994). Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline. J. Biol. Chem.269, 26677–26683.

  • Pubmed Abstract
  • Google Scholar

• 65

  FurukawaT.MyerburgR. J.FurukawaN.BassettA. L.KimuraS. (1990). Differences in transient outward currents of feline endocardial and epicardial myocytes. Circ. Res.67, 1287–1291. 10.1161/01.RES.67.5.1287

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 66

  GaoX.ZhangH.SchmidtA. M.ZhangC. (2008). AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am. J. Physiol. Heart Circ. Physiol. 295, H491–H498. 10.1152/ajpheart.00464.2008

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 67

  GonzálezM.FloresC.PearsonJ. D.CasanelloP.SobreviaL. (2004). Cell signalling-mediating insulin increase of mRNA expression for cationic amino acid transporters-1 and -2 and membrane hyperpolarization in human umbilical vein endothelial cells. Pflugers Arch. 448, 383–394. 10.1007/s00424-004-1261-x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 68

  GonzálezM.GallardoV.RodríguezN.SalomónC.WestermeierF.Guzmán-GutiérrezE.et al. (2011). Insulin-stimulated L-arginine transport requires SLC7A1 gene expression and is associated with human umbilical vein relaxation. J. Cell. Physiol. 226, 2916–2924. 10.1002/jcp.22635

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 69

  GonzálezM.RojasS.AvilaP.CabreraL.VillalobosR.PalmaC.et al. (2015). Insulin reverses D-glucose-increased nitric oxide and reactive oxygen species generation in human umbilical vein endothelial cells. PLoS ONE10:e0122398. 10.1371/journal.pone.0122398

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 70

  GreggE.LiY.WangJ.RiosN.AliM.RolkaD.et al. (2014). Changes in Diabetes-Related Complications in the United States, 1990–2010. N. Engl. J. Med.370, 1514–1523. 10.1056/NEJMoa1310799

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 71

  GrubbS.CalloeK.ThomsenM. B. (2012). Impact of KChIP2 on cardiac electrophysiology and the progression of heart failure. Front. Physiol.3:118. 10.3389/fphys.2012.00118

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 72

  GuoL.TianS.ChenY.MaoY.CuiS.HuA.et al. (2015). CAT-1 as a novel CAM stabilizes endothelial integrity and mediates the protective actions of l-Arg via a NO-independent mechanism. J. Mol. Cell. Cardiol.87, 180–191. 10.1016/j.yjmcc.2015.08.011

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 73

  GuoS. (2014). Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J. Endocrinol.220, T1–T23. 10.1530/JOE-13-0327

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 74

  GuoW.JungW. E.MarionneauC.AimondF.XuH.YamadaK. A.et al. (2005). Targeted deletion of Kv4.2 eliminates Ito,f and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction. Circ. Res.97, 1342–1350. 10.1161/01.RES.0000196559.63223.aa

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 75

  GuoW.LiH.AimondF.JohnsD. C.RhodesK. J.NerbonneJ. M.et al. (2002). Role of heteromultimers in the generation of myocardial transient outward K⁺ currents. Circ. Res.90, 586–593. 10.1161/01.RES.0000012664.05949.E0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 76

  GuoW.LiH.LondonB.NerbonneJ. M. (2000). Functional consequences of elimination of Ito,f and Ito,s: early afterdepolarizations, atrioventricular block, and ventricular arrhythmias in mice lacking Kv1.4 and expressing a dominant-negative Kv4 α subunit. Circ. Res.87, 73–79. 10.1161/01.RES.87.1.73

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 77

  GuoW.XuH.LondonB.NerbonneJ. M. (1999). Molecular basis of transient outward K⁺ current diversity in mouse ventricular myocytes. J. Physiol.521, 587–599. 10.1111/j.1469-7793.1999.00587.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 78

  Guzmán-GutiérrezE.WestermeierF.SalomónC.GonzálezM.PardoF.LeivaA.et al. (2012). Insulin-increased L-arginine transport requires A(2A) adenosine receptors activation in human umbilical vein endothelium. PLoS ONE7:e41705. 10.1371/journal.pone.0041705

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 79

  HiraokaM.KawanoS. (1989). Calcium-sensitive and insensitive transient outward current in rabbit ventricular myocytes. J. Physiol.410, 187–212. 10.1113/jphysiol.1989.sp017528

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 80

  HowarthF.JacobsonM.QureshiM.ShafiullahM.HameedR.ZilahiE.et al. (2009). Altered gene expression may underlie prolonged duration of the QT interval and ventricular action potential in streptozotocin-induced diabetic rat heart. Mol. Cell. Biochem.328, 57–65. 10.1007/s11010-009-0074-9

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 81

  HuangE. S.LaiteerapongN.LiuJ. Y.JohnP. M.MoffetH. H.KarterA. J. (2014). Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern. Med.174, 251–258. 10.1001/jamainternmed.2013.12956

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 82

  International Diabetes Federation (IFD) (2013). Diabetes Atlas, 6th Edn. Available online at: www.idf.org/diabetesatlas

  • Google Scholar

• 83

  JohnsD. C.NussH. B.MarbanE. (1997). Suppression of neuronal and cardiac transient outward currents by viral gene transfer of dominant-negative Kv4.2 constructs. J. Biol. Chem.272, 31598–31603. 10.1074/jbc.272.50.31598

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 84

  KääbS.DixonJ.DucJ.AshenD.NäbauerM.BeuckelmannD. J.et al. (1998). Molecular basis of transient outward potassium current downregulation in human heart failure. A decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation98, 1383–1393. 10.1161/01.CIR.98.14.1383

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 85

  KannelW. B.McGeeD. L. (1979). Diabetes and cardiovascular disease: the Framingham study. JAMA241, 2035–2038. 10.1001/jama.1979.03290450033020

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 86

  KannoS.SaffitzJ. E. (2001). The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc. Pathol.10, 169–177. 10.1016/S1054-8807(01)00078-3

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 87

  KarbachS.SimonA.SlenzkaA.JaeneckeI.HabermeierA.MartinéU.et al. (2011). Relative contribution of different l-arginine sources to the substrate supply of endothelial nitric oxide synthase. J. Mol. Cell. Cardiol.51, 855–861. 10.1016/j.yjmcc.2011.07.024

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 88

  KayeD. M.ParnellM. M.AhlersB. A. (2002). Reduced myocardial and systemic L-arginine uptake in heart failure. Circ. Res.91, 1198–1203. 10.1161/01.RES.0000047506.52381.90

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 89

  KimY. J.ParkH. S.LeeH. Y.HaE. H.SuhS. H.OhS. K. (2006). Reduced L-arginine level and decreased placental eNOS activity in preeclampsia. Placenta27, 438–444. 10.1016/j.placenta.2005.04.011

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 90

  KizhatilK.AlbrittonL. M. (2002). System y+ localizes to different membrane subdomains in the basolateral plasma membrane of epithelial cells. Am. J. Physiol. Cell. Physiol. 283, C1784–C1794. 10.1152/ajpcell.00061.2002

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 91

  KléberA. G.RudyY. (2004). Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol. Rev.84, 431–488. 10.1152/physrev.00025.2003

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 92

  KnowlesR. G.MoncadaS. (1994). Nitric oxide synthases in mammals. Biochem. J.298, 249–258. 10.1042/bj2980249

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 93

  KohlhaasC. F.MorrowV. A.JhakraN.PatilV.ConnellJ. M.PetrieJ. R.et al. (2011). Insulin rapidly stimulates L-arginine transport in human aortic endothelial cells via Akt. Biochem. Biophys. Res. Commun.412, 747–751. 10.1016/j.bbrc.2011.08.048

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 94

  KolterT.UphuesI.EckelJ. (1997). Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats. Am. J. Physiol.273, E59–E67.

  • Pubmed Abstract
  • Google Scholar

• 95

  KongW.PoS.YamagishiT.AshenM. D.StettenG.TomaselliG. F. (1998). Isolation and characterization of the human gene encoding Ito: further diversity by alternative mRNA splicing. Am. J. Physiol.275, H1963–H1970.

  • Pubmed Abstract
  • Google Scholar

• 96

  KuoH. C.ChengC. F.ClarkR. B.LinJ. J.LinJ. L.HoshijimaM.et al. (2001). A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of Ito and confers susceptibility to ventricular tachycardia. Cell107, 801–813. 10.1016/S0092-8674(01)00588-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 97

  LazarD. F.WieseR. J.BradyM. J.MastickC. C.WatersS. B.SaltielA. R.et al. (1995). Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J. Biol. Chem.270, 20801–20807. 10.1074/jbc.270.35.20801

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 98

  LengyelC.VirágL.BíróT.JostN.MagyarJ.BiliczkiP.et al. (2007). Diabetes mellitus attenuates the repolarization reserve in mammalian heart. Cardiovasc. Res.73, 512–520. 10.1016/j.cardiores.2006.11.010

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 99

  LesniewskiL. A.DonatoA. J.BehnkeB. J.WoodmanC. R.LaughlinM. H.RayC. A.et al. (2008). Decreased NO signaling leads to enhanced vasoconstrictor responsiveness in skeletal muscle arterioles of the ZDF rat prior to overt diabetes and hypertension. Am. J. Physiol. Heart Circ. Physiol. 294, H1840–H1850. 10.1152/ajpheart.00692.2007

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 100

  LitovskyS. H.AntzelevitchC. (1998). Transient outward current prominent in canine ventricular epicardium but not endocardium. Circ. Res.62, 116–126. 10.1161/01.RES.62.1.116

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 101

  LiuJ. E.PalmieriV.RomanM. J.BellaJ. N.FabsitzR.HowardB. V.et al. (2001). The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J. Am. Coll. Cardiol.37, 1943–1949. 10.1016/S0735-1097(01)01230-X

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 102

  LiuW. J.WangH. T.ChenW. W.DengJ. X.JiangY.LiuJ. (2008). Co-expression of KCNE2 and KChIP2c modulates the electrophysiological properties of Kv4.2 current in COS-7 cells. Acta Pharmacol. Sin.29, 653–660. 10.1111/j.1745-7254.2008.00804.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 103

  LondonB.WangD. W.HillJ. A.BennettP. B. (1998). The transient outward current in mice lacking the potassium channel gene Kv1.4. J. Physiol.509, 171–182. 10.1111/j.1469-7793.1998.171bo.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 104

  Lopez-IzquierdoA.PereiraR. O.WendeA. R.PunskeB. B.AbelE. D.Tristani-FirouziM. (2014). The absence of insulin signaling in the heart induces changes in potassium channel expression and ventricular repolarization. Am. J. Physiol. Heart Circ. Physiol.306, H747–H754. 10.1152/ajpheart.00849.2013

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 105

  LuX.SilverJ. (2000). Ecotropic murine leukemia virus receptor is physically associated with caveolin and membrane rafts. Virology276, 251–258. 10.1006/viro.2000.0555

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 106

  LuoC. H.RudyY. (1994a). A dynamic model of the cardiac ventricular action potential. I. Simulations of ionic currents and concentration changes. Circ. Res. 74, 1071–1096. 10.1161/01.RES.74.6.1071

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 107

  LuoC. H.RudyY. (1994b). A dynamic model of the cardiac ventricular action potential. II. After depolarizations, triggered activity, and potentiation. Circ. Res. 74, 1097–1113. 10.1161/01.RES.74.6.1097

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 108

  MacKinnonR. (1991). Determination of the subunit stoichiometry of a voltage-activated potassium channel. Nature350, 232–235. 10.1038/350232a0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 109

  MagyarJ.RusznákZ.SzentesiP.SzûcsG.KovácsL. (1992). Action potentials and potassium currents in rat ventricular muscle during experimental diabetes. J. Mol. Cell. Cardiol.24, 841–853. 10.1016/0022-2828(92)91098-P

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 110

  MandaviaC. H.AroorA. R.DemarcoV. G.SowersJ. R. (2013). Molecular and metabolic mechanisms of cardiac dysfunction in diabetes. Life Sci.92, 601–608. 10.1016/j.lfs.2012.10.028

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 111

  MannG. E.YudilevichD. L.SobreviaL. (2003). Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol. Rev. 83, 183–252. 10.1152/physrev.00022.2002

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 112

  MasudaM.KakushimaN.WiltS. G.RuscettiS. K.HoffmanP. M.IwamotoA. (1999). Analysis of receptor usage by ecotropic murine retroviruses, using green fluorescent protein-tagged cationic amino acid transporters. J. Virol. 73, 8623–8629.

  • Pubmed Abstract
  • Google Scholar

• 113

  MazumderP. K.O'NeillB. T.RobertsM. W.BuchananJ.BoudinaS.AbelE. D.et al. (2004). Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes53, 2366–2374. 10.2337/diabetes.53.9.2366

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 114

  McCrossanZ. A.AbbottG. W. (2004). The MinK-related peptides. Neuropharmacology47, 787–821. 10.1016/j.neuropharm.2004.06.018

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 115

  McDonaldK. K.ZharikovS.BlockE. R.KilbergM. S. (1997). A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the “arginine paradox”. J. Biol. Chem. 272, 31213–31216. 10.1074/jbc.272.50.31213

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 116

  McKeownL.SwantonL.RobinsonP.JonesO. T. (2008). Surface expression and distribution of voltage-gated potassium channels in neurons. Mol. Membr. Biol.25, 332–343. 10.1080/09687680801992470

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 117

  MuniyappaR.MontagnaniM.KohK. K.QuonM. J. (2007). Cardiovascular actions of insulin. Endocr. Rev.28, 463–491. 10.1210/er.2007-0006

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 118

  MunkA. A.AdjemianR. A.ZhaoJ.OgbagherrielA.ShrierA. (1996). Electrophysiological properties of morphologically distinct cells isolated from the rabbit atrio-ventricular node. J. Physiol. 493, 801–818. 10.1113/jphysiol.1996.sp021424

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 119

  MuñozG.San MartínR.FaríasM.CeaL.VecchiolaA.CasanelloP.et al. (2006). Insulin restores glucose inhibition of adenosine transport by increasing the expression and activity of the equilibrative nucleoside transporter 2 in human umbilical vein endothelium. J. Cell. Physiol. 209, 826–835. 10.1002/jcp.20769

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 120

  NerbonneJ. M. (2000). Molecular basis of functional voltage-gated K⁺ channel diversity in the mammalian myocardium. J. Physiol.525, 285–298. 10.1111/j.1469-7793.2000.t01-1-00285.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 121

  NerbonneJ. M.GuoW. (2002). Heterogeneous expression of voltage-gated potassium channels in the heart: roles in normal excitation and arrhythmias. J. Cardiovasc. Electrophysiol.13, 406–409. 10.1046/j.1540-8167.2002.00406.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 122

  NerbonneJ. M.KassR. S. (2005). Physiology and molecular biology of ion channels contributing to ventricular repolarization. Physiol. Rev.85, 1205–1253. 10.1152/physrev.00002.2005

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 123

  NielsenN. H.WinkelB. G.KantersJ. K.SchmittN.Hofman-BangJ.JensenH. S.et al. (2007). Mutations in the Kv1.5 channel gene KCNA5 in cardiac arrest patients. Biochem. Biophys. Res. Commun.354, 776–782. 10.1016/j.bbrc.2007.01.048

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 124

  NishiyamaA.IshiiD. N.BackxP. H.PulfordB. E.BirksB. R.TamkunM. M. (2001). Altered K⁺ channel gene expression in diabetic rat ventricle: isoform switching between Kv42 and Kv14. Am. J. Physiol. Heart Circ. Physiol.281, H1800–H1807. Available online at: http://ajpheart.physiology.org/content/281/4/H1800

  • Google Scholar

• 125

  NiwaN.NerbonneJ. M. (2010). Molecular determinants of cardiac transient outward potassium current (Ito) expression and regulation. J. Mol. Cell. Cardiol.48, 12–25. 10.1016/j.yjmcc.2009.07.013

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 126

  NystromF. H.QuonM. J. (1999). Insulin signalling: metabolic pathways and mechanisms for specificity. Cell Signal.11, 563–574. 10.1016/S0898-6568(99)00025-X

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 127

  PalacínM.EstévezR.BertranJ.ZorzanoA. (1998). Molecular biology of mammalian plasma membrane amino acid transporters. Physiol. Rev. 78, 969–1054.

  • Pubmed Abstract
  • Google Scholar

• 128

  PalmerR. M.ReesD. D.AshtonD. S.MoncadaS. (1988). L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153, 1251–1256. 10.1016/S0006-291X(88)81362-7

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 129

  PatelS. P.CampbellD. L. (2005). Transient outward potassium current, ‘Ito’, phenotypes in the mammalian left ventricle: underlying molecular, cellular and biophysical mechanisms. J. Physiol.569, 7–39. 10.1113/jphysiol.2005.086223

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 130

  PattiM.KahnC. (1998). The insulin receptor: a critical link in glucose homeostasis and insulin action. J. Basic Clin. Physiol. Pharmacol.9, 89–109. 10.1515/JBCPP.1998.9.2-4.89

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 131

  Perez-ReyesE. (2002). Molecular physiology of low voltage-activated T-type calcium channels. Physiol. Rev. 83, 117–161. 10.1152/physrev.00018.2002

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 132

  PoS.SnydersD. J.BakerR.TamkunM. M.BennettP. B. (1992). Functional expression of an inactivating potassium channel cloned from human heart. Circ. Res.71, 732–736. 10.1161/01.RES.71.3.732

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 133

  PoornimaI. G.ParikhP.ShannonR. P. (2006). Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ. Res.98, 596–605. 10.1161/01.RES.0000207406.94146.c2

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 134

  QinD.HuangB.DengL.El-AdawiH.GangulyK.SowersJ. R.et al. (2001). Downregulation of K⁺ channel genes expression in type I diabetic cardiomyopathy. Biochem. Biophys. Res. Commun.283, 549–553. 10.1006/bbrc.2001.4825

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 135

  QuijanoC.CastroL.PeluffoG.ValezV.RadiR. (2007). Enhanced mitochondrial superoxide in hyperglycemic endothelial cells: direct measurements and formation of hydrogen peroxide and peroxynitrite. Am. J. Physiol. Heart Circ. Physiol.293, H3404–H3414. 10.1152/ajpheart.00761.2007

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 136

  RajapakseN. W.ChongA. L.ZhangW. Z.KayeD. M. (2013). Insulin-mediated activation of the L-arginine nitric oxide pathway in man, and its impairment in diabetes. PLoS ONE8:e61840. 10.1371/journal.pone.0061840

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 137

  Rask-MadsenC.KingG. L. (2007). Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes. Nat. Clin. Pract. Endocrinol. Metab. 3, 46–56. 10.1038/ncpendmet0366

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 138

  RoberdsS. L.TamkunM. M. (1991). Cloning and tissue-specific expression of five voltage-gated potassium channel cDNAs expressed in rat heart. Proc. Natl. Acad. Sci. U.S.A. 88, 1798–1802. 10.1073/pnas.88.5.1798

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 139

  RoepkeT. K.KontogeorgisA.OvanezC.XuX.YoungJ. B.PurtellK.et al. (2008). Targeted deletion of kcne2 impairs ventricular repolarization via disruption of IK, slow1 and Ito,f. FASEB J.22, 3648–3660. 10.1096/fj.08-110171

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 140

  RozanskiG. J.XuZ. (2002). A metabolic mechanism for cardiac K⁺ channel remodelling. Clin. Exp. Pharmacol. Physiol.29, 132–137. 10.1046/j.1440-1681.2002.03618.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 141

  RozanskiG. J.XuZ.ZhangK.PatelK. P. (1998). Altered K⁺ current of ventricular myocytes in rats with chronic myocardial infarction. Am. J. Physiol. Heart Circ. Physiol.274, H259–H265.

  • Pubmed Abstract
  • Google Scholar

• 142

  RublerS.DlugashJ.YuceogluY. Z.KumralT.BranwoodA. W.GrishmanA. (1972). New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am. J. Cardiol.30, 595–602. 10.1016/0002-9149(72)90595-4

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 143

  SaltielA. R.KahnC. R. (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature414, 799–806. 10.1038/414799a

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 144

  San MartínR.SobreviaL. (2006). Gestational diabetes and the adenosine/L-arginine/nitric oxide (ALANO) pathway in human umbilical vein endothelium. Placenta27, 1–10. 10.1016/j.placenta.2005.01.011

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 145

  SchinzariF.IantornoM.CampiaU.MoresN.RovellaV.TesauroM.et al. (2015). Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab.309, E787–E792. 10.1152/ajpendo.00278.2015

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 146

  SchlaichM. P.ParnellM. M.AhlersB. A.FinchS.MarshallT.ZhangW. Z.et al. (2004). Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects. Circulation110, 3680–3686. 10.1161/01.CIR.0000149748.79945.52

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 147

  SchultzeS. M.HemmingsB. A.NiessenM.TschoppO. (2012). PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis. Expert. Rev. Mol. Med.14, e1. 10.1017/S1462399411002109

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 148

  SessaW. C. (1994). The nitric oxide synthase family of proteins. J. Vasc. Res. 31, 131–143. 10.1159/000159039

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 149

  ShiY.VanhoutteP. M. (2008). Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats. Br. J. Pharmacol. 154, 639–651. 10.1038/bjp.2008.110

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 150

  ShimoniY. (2001). Inhibition of the formation or action of angiotensin II reverses attenuated K⁺ currents in type 1 and type 2 diabetes. J. Physiol.537, 83–92. 10.1111/j.1469-7793.2001.0083k.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 151

  ShimoniY.ChuangM.AbelE. D.SeversonD. L. (2004). Gender-dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice. J. Physiol.555, 345–354. 10.1113/jphysiol.2003.055590

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 152

  ShimoniY.EwartH. S.SeversonD. (1998). Type I and II models of diabetes produce different modifications of K⁺ currents in rat heart: role of insulin. J. Physiol.507, 485–496. 10.1111/j.1469-7793.1998.485bt.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 153

  ShimoniY.EwartH. S.SeversonD. (1999). Insulin stimulation of rat ventricular K⁺ currents depends on the integrity of the cytoskeleton. J. Physiol.514, 735–745. 10.1111/j.1469-7793.1999.735ad.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 154

  ShimoniY.FirekL.SeversonD.GilesW. (1994). Short-term diabetes alters K⁺ currents in rat ventricular myocytes. Circ. Res.74, 620–628. 10.1161/01.RES.74.4.620

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 155

  ShinS.MohanS.FungH. L. (2011). Intracellular L-arginine concentration does not determine NO production in endothelial cells: implications on the “L-arginine paradox”. Biochem. Biophys. Res. Commun. 414, 660–663. 10.1016/j.bbrc.2011.09.112

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 156

  ShioiT.KangP. M.DouglasP. S.HampeJ.YballeC. M.LawittsJ.et al. (2000). The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 19, 2537–2548. 10.1093/emboj/19.11.2537

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 157

  SimonA.KarbachS.HabermeierA.ClossE. I. (2013). Decoding the substrate supply to human neuronal nitric oxide synthase. PLoS ONE8:e67707. 10.1371/journal.pone.0067707

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 158

  SnydersD. J. (1999). Structure and function of cardiac potassium channels. Cardiovasc. Res.42, 377–390. 10.1016/S0008-6363(99)00071-1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 159

  SnydersD. J.TamkunM. M.BennettP. B. (1993). A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expression. J. Gen. Physiol.101, 513–543. 10.1085/jgp.101.4.513

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 160

  SobreviaL.GonzálezM. (2009). A role for insulin on L-arginine transport in fetal endothelial dysfunction in hyperglycaemia. Curr. Vasc. Pharmacol. 7, 467–474. 10.2174/157016109789043919

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 161

  SobreviaL.NadalA.YudilevichD. L.MannG. E. (1996). Activation of L-arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells. J. Physiol. 490, 775–781. 10.1113/jphysiol.1996.sp021185

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 162

  SobreviaL.YudilevichD. L.MannG. E. (1997). Activation of A2-purinoceptors by adenosine stimulates L-arginine transport (system y+) and nitric oxide synthesis in human fetal endothelial cells. J. Physiol. 499, 135–140. 10.1113/jphysiol.1997.sp021916

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 163

  SridharA.da CunhaD. N.LacombeV. A.ZhouQ.FoxJ. J.HamlinR. L.et al. (2007). The plateau outward current in canine ventricle, sensitive to 4-aminopyridine, is a constitutive contributor to ventricular repolarization. Br. J. Pharmacol.152, 870–879. 10.1038/sj.bjp.0707403

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 164

  SrinivasanS.HatleyM. E.BolickD. T.PalmerL. A.EdelsteinD.BrownleeM.et al. (2004). Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia47, 1727–1734. 10.1007/s00125-004-1525-1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 165

  SteinbergH. O.BaronA. D. (2002). Vascular function, insulin resistance and fatty acids. Diabetologia45, 623–634. 10.1007/s00125-002-0800-2

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 166

  StrausS. M.KorsJ. A.De BruinM. L.van der HooftC. S.HofmanA.HeeringaJ.et al. (2006). Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J. Am. Coll. Cardiol.47, 362–367. 10.1016/j.jacc.2005.08.067

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 167

  TamkunM. M.KnothK. M.WalbridgeJ. A.KroemerH.RodenD. M.GloverD. M. (1991). Molecular cloning and characterization of two voltage-gated K⁺ channel cDNAs from human ventricle. FASEB J.5, 331–337.

  • Pubmed Abstract
  • Google Scholar

• 168

  Torres-JacomeJ.GallegoM.Rodríguez-RobledoJ. M.Sanchez-ChapulaJ. A.CasisO. (2013). Improvement of the metabolic status recovers cardiac potassium channel synthesis in experimental diabetes. Acta Physiol. (Oxf.)207, 447–459. 10.1111/apha.12043

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 169

  Tseng-CrankJ. C.TsengG. N.SchwartzA.TanouyeM. A. (1990). Molecular cloning and functional expression of a potassium channel cDNA isolated from a rat cardiac library. FEBS Lett.268, 63–68. 10.1016/0014-5793(90)80973-M

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 170

  UiM.OkadaT.HazekiK.HazekiO. (1995). Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem. Sci.20, 303–307. 10.1016/S0968-0004(00)89056-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 171

  Van WagonerD.PondA. L.McCarthyP. M.TrimmerJ. S.NerbonneJ. M. (1997). Outward K⁺ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ. Res.80, 772–781. 10.1161/01.RES.80.6.772

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 172

  VanhoutteP. M. (2003). Endothelial control of vasomotor function: from health to coronary disease. Circ. J.67, 572–575. 10.1253/circj.67.572

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 173

  VanhoutteP. M.TangE. H. (2008). Endothelium-dependent contractions: when a good guy turns bad!J. Physiol.586, 5295–5304. 10.1113/jphysiol.2008.161430

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 174

  VarróA.NanasiP. P.LathropD. A. (1993). Potassium currents in isolated human atrial and ventricular cardiocytes. Acta Physiol. Scand.149, 133–142. 10.1111/j.1748-1716.1993.tb09605.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 175

  VásquezG.SanhuezaF.VásquezR.GonzálezM.San MartínR.CasanelloP.et al. (2004). Role of adenosine transport in gestational diabetes-induced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. J. Physiol. 560, 111–122. 10.1113/jphysiol.2004.068288

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 176

  VásquezR.FaríasM.VegaJ. L.MartinR. S.VecchiolaA.CasanelloP.et al. (2007). D-glucose stimulation of L-arginine transport and nitric oxide synthesis results from activation of mitogen-activated protein kinases p42/44 and Smad2 requiring functional type II TGF-beta receptors in human umbilical vein endothelium. J. Cell. Physiol. 212, 626–632. 10.1002/jcp.21057

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 177

  VeglioM.BorraM.StevensL. K.FullerJ. H.PerinP. C. (1999). The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM complication study group. Diabetologia42, 68–75. 10.1007/s001250051115

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 178

  VeglioM.BrunoG.BorraM.MacchiaG.BargeroG.D'ErricoN.et al. (2002a). Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J. Intern. Med.251, 317–324. 10.1046/j.1365-2796.2002.00955.x

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 179

  VeglioM.ChinagliaA.Cavallo-PerinP. (2004). QT interval, cardiovascular risk factors and risk of death in diabetes. J. Endocrinol. Invest.27, 175–181. 10.1007/BF03346265

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 180

  VeglioM.GiuntiS.StevensL. K.FullerJ. H.PerinP. C. (2002b). Prevalence of Q-T interval dispersion in type 1 diabetes and its relation with cardiac ischemia: the EURODIAB IDDM complications study group. Diabetes Care25, 702–707. 10.2337/diacare.25.4.702

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 181

  VerreyF.ClossE. I.WagnerC. A.PalacinM.EndouH.KanaiY. (2004). CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch.447, 532–542. 10.1007/s00424-003-1086-z

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 182

  WangZ.FengJ.ShiH.PondA.NerbonneJ. M.NattelS. (1999). Potential molecular basis of different physiological properties of the transient outward K⁺ current in rabbit and human atrial myocytes. Circ. Res.84, 551–561. 10.1161/01.RES.84.5.551

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 183

  WangZ.FerminiB.NattelS. (1993). Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K⁺ current similar to Kv1.5 cloned channel currents. Circ. Res.73, 1061–1076. 10.1161/01.RES.73.6.1061

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 184

  WettwerE.AmosG.GathJ.ZerkowskiH. R.ReidemeisterJ. C.RavensU. (1993). Transient outward current in human and rat ventricular myocytes. Cardiovasc. Res.27, 1662–1669. 10.1093/cvr/27.9.1662

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 185

  WhiteM. F. (2003). Insulin signaling in health and disease. Science302, 1710–1711. 10.1126/science.1092952

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 186

  WickendenA. D.JeglaT. J.KaprielianR.BackxP. H. (1999). Regional contributions of Kv1.4, Kv4.2, and Kv4.3 to transient outward K⁺ current in rat ventricle. Am. J. Physiol.276, H1599–H1607.

  • Pubmed Abstract
  • Google Scholar

• 187

  WierzbickiA. S.ChowienczykP. J.CockcroftJ. R.BrettS. E.WattsG. F.JenkinsB. S.et al. (2004). Cardiovascular risk factors and endothelial dysfunction. Clin. Sci. (Lond.)107, 609–615. 10.1042/CS20040078

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 188

  WilliamsS. B.CuscoJ. A.RoddyM. A.JohnstoneM. T.CreagerM. A. (1996). Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 27, 567–574. 10.1016/0735-1097(95)00522-6

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 189

  WolfS.JanzenA.VékonyN.MartinéU.StrandD.ClossE. I. (2002). Expression of solute carrier 7A4 (SLC7A4) in the plasma membrane is not sufficient to mediate amino acid transport activity. Biochem. J. 364, 767–775. 10.1042/bj20020084

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 190

  World Health Organization (WHO) (1998). Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva.

  • Google Scholar

• 191

  XiongY.FuY. F.FuS. H.ZhouH. H. (2003). Elevated levels of the serum endogenous inhibitor of nitric oxide synthase and metabolic control in rats with streptozotocin-induced diabetes. J. Cardiovasc. Pharmacol. 42, 191–196. 10.1097/00005344-200308000-00006

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 192

  XuH.GuoW.NerbonneJ. M. (1999). Four kinetically distinct depolarization-activated K⁺ currents in adult mouse ventricular myocytes. J. Gen. Physiol.113, 661–678. 10.1085/jgp.113.5.661

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 193

  XuZ.PatelK. P.LouM. F.RozanskiG. J. (2002). Up-regulation of K(+) channels in diabetic rat ventricular myocytes by insulin and glutathione. Cardiovasc. Res.53, 80–88. 10.1016/S0008-6363(01)00446-1

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 194

  XuZ.PatelK. P.RozanskiJ. G. (1996). Metabolic basis of decreased transient outward K⁺ current in ventricular myocytes from diabetic rats. Am. J. Physiol. Heart Circ. Physiol.271, H2190–H2196.

  • Pubmed Abstract
  • Google Scholar

• 195

  YangX.SalasP. J.PhamT. V.WasserlaufB. J.SmetsM. J.MyerburgR. J.et al. (2002). Cytoskeletal actin microfilaments and the transient outward potassium current in hypertrophied rat ventriculocytes. J. Physiol.541, 411–421. 10.1113/jphysiol.2002.019562

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 196

  YangZ.VenardosK.JonesE.MorrisB. J.Chin-DustingJ.KayeD. M. (2007). Identification of a novel polymorphism in the 3′UTR of the L-arginine transporter gene SLC7A1: contribution to hypertension and endothelial dysfunction. Circulation115, 1269–1274. 10.1161/circulationaha.106.665836

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 197

  ZhangY.PostW. S.DalalD.Blasco-ColmenaresE.TomaselliG. F.GuallarE. (2011). QT-interval duration and mortality rate. Results from the third national health and nutrition examination survey. Arch. Intern. Med.171, 1727–1733. 10.1001/archinternmed.2011.433

  • Pubmed Abstract
  • CrossRef
  • Google Scholar